Axon Enterprise, Inc $AXON Shares Bought by D.A. Davidson & CO.

D.A. Davidson & CO. lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 58.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,144 shares of the biotechnology company's stock after acquiring an additional 5,958 shares during the quarter. D.A. Davidson & CO.'s holdings in Axon Enterprise were worth $9,050,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Conestoga Capital Advisors LLC acquired a new stake in Axon Enterprise in the second quarter valued at $221,000. Martin Capital Advisors LLP acquired a new position in shares of Axon Enterprise during the 2nd quarter worth $365,000. EverSource Wealth Advisors LLC raised its stake in shares of Axon Enterprise by 111.2% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,666 shares of the biotechnology company's stock worth $2,055,000 after buying an additional 1,930 shares during the last quarter. Tradewinds Capital Management LLC boosted its position in shares of Axon Enterprise by 5,020.0% in the 2nd quarter. Tradewinds Capital Management LLC now owns 256 shares of the biotechnology company's stock worth $144,000 after buying an additional 251 shares in the last quarter. Finally, Lodestone Wealth Management LLC boosted its position in shares of Axon Enterprise by 279.8% in the 2nd quarter. Lodestone Wealth Management LLC now owns 357 shares of the biotechnology company's stock worth $200,000 after buying an additional 263 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In related news, insider Isaiah Fields sold 2,000 shares of the company's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the transaction, the insider directly owned 52,813 shares in the company, valued at approximately $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 20,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the transaction, the chief executive officer owned 3,060,997 shares in the company, valued at $1,530,498,500. This trade represents a 0.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. Company insiders own 4.20% of the company's stock.

Wall Street Analysts Forecast Growth

AXON has been the subject of several recent research reports. Citizens Jmp restated a "market outperform" rating and set a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. TD Cowen reiterated a "buy" rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. The Goldman Sachs Group reissued a "buy" rating and set a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. Royal Bank Of Canada restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $730.92.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $612.83 on Friday. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $794.29. The stock has a market capitalization of $49.78 billion, a P/E ratio of 254.29, a P/E/G ratio of 12.56 and a beta of 1.39. The firm's 50-day moving average is $526.06 and its two-hundred day moving average is $474.40. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company's quarterly revenue was up 35.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.12 earnings per share. Equities analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source